BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1394 related articles for article (PubMed ID: 18249305)

  • 1. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.
    Karadag F; Kirdar S; Karul AB; Ceylan E
    Eur J Intern Med; 2008 Mar; 19(2):104-8. PubMed ID: 18249305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease.
    Valipour A; Schreder M; Wolzt M; Saliba S; Kapiotis S; Eickhoff P; Burghuber OC
    Clin Sci (Lond); 2008 Oct; 115(7):225-32. PubMed ID: 18307413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Systemic inflammation during exacerbations of chronic obstructive pulmonary disease].
    Malo O; Sauleda J; Busquets X; Miralles C; Agustí AG; Noguera A
    Arch Bronconeumol; 2002 Apr; 38(4):172-6. PubMed ID: 11953269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of serum leptin and tumor necrosis factor-alpha in malnutrition of male chronic obstructive pulmonary disease patients.
    Yang YM; Sun TY; Liu XM
    Chin Med J (Engl); 2006 Apr; 119(8):628-33. PubMed ID: 16635406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating visfatin in chronic obstructive pulmonary disease.
    Liu X; Ji Y; Chen J; Li S; Luo F
    Nutrition; 2009 Apr; 25(4):373-8. PubMed ID: 19056239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adiponectin as a biomarker of systemic inflammatory response in smoker patients with stable and exacerbation phases of chronic obstructive pulmonary disease.
    Kirdar S; Serter M; Ceylan E; Sener AG; Kavak T; Karadağ F
    Scand J Clin Lab Invest; 2009; 69(2):219-24. PubMed ID: 18946779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased serum inflammatory markers in the absence of clinical and skeletal muscle inflammation in patients with chronic obstructive pulmonary disease.
    Piehl-Aulin K; Jones I; Lindvall B; Magnuson A; Abdel-Halim SM
    Respiration; 2009; 78(2):191-6. PubMed ID: 19270439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of BMI in patients with COPD.
    Karadag F; Karul AB; Cildag O; Altun C; Gurgey O
    Respirology; 2004 Mar; 9(1):70-5. PubMed ID: 14982605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma leptin and adiponectin in COPD exacerbations: associations with inflammatory biomarkers.
    Krommidas G; Kostikas K; Papatheodorou G; Koutsokera A; Gourgoulianis KI; Roussos C; Koulouris NG; Loukides S
    Respir Med; 2010 Jan; 104(1):40-6. PubMed ID: 19782551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlates of erectile dysfunction in moderate-to-severe chronic obstructive pulmonary disease patients.
    Karadag F; Ozcan H; Karul AB; Ceylan E; Cildag O
    Respirology; 2007 Mar; 12(2):248-53. PubMed ID: 17298458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between triiodothyronine and proinflammatory cytokines in chronic heart failure.
    Lubrano V; Pingitore A; Carpi A; Iervasi G
    Biomed Pharmacother; 2010 Mar; 64(3):165-9. PubMed ID: 19926244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly elevated C-reactive protein levels in obese patients with COPD: a fat chance?
    Breyer MK; Spruit MA; Celis AP; Rutten EP; Janssen PP; Wouters EF;
    Clin Nutr; 2009 Dec; 28(6):642-7. PubMed ID: 19540024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leptin and TNF-alpha levels in patients with chronic obstructive pulmonary disease and their relationship to nutritional parameters.
    Calikoglu M; Sahin G; Unlu A; Ozturk C; Tamer L; Ercan B; Kanik A; Atik U
    Respiration; 2004; 71(1):45-50. PubMed ID: 14872110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The influence of inflammatory process on the ventilatory impairment in patients with stable chronic obstructive pulmonary disease].
    Komnata K
    Pneumonol Alergol Pol; 2010; 78(4):271-8. PubMed ID: 20665447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between serum biomarkers and BODE index in patients with stable COPD.
    Liu SF; Chin CH; Wang CC; Lin MC
    Respirology; 2009 Sep; 14(7):999-1004. PubMed ID: 19740260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Systemic inflammation among stable ex smokers with chronic obstructive pulmonary disease].
    Morales S A; Dreyse D J; Díaz P O; Saldías P F; Carrasco M; Lisboa B C
    Rev Med Chil; 2010 Aug; 138(8):957-64. PubMed ID: 21140052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exhaled nitric oxide, systemic inflammation, and the spirometric response to inhaled fluticasone propionate in severe chronic obstructive pulmonary disease: a prospective study.
    Kunisaki KM; Rice KL; Janoff EN; Rector TS; Niewoehner DE
    Ther Adv Respir Dis; 2008 Apr; 2(2):55-64. PubMed ID: 19124359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nutritional status in relation to respiratory impairment and systemic inflammation in patients with acute exacerbations of COPD.
    Skyba P; Kluchova Z; Joppa P; Petrasova D; Tkacova R
    Med Sci Monit; 2009 Oct; 15(10):CR528-533. PubMed ID: 19789512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic pulmonary hyperinflation and low grade systemic inflammation in stable COPD patients.
    Gatta D; Aliprandi G; Pini L; Zanardini A; Fredi M; Tantucci C
    Eur Rev Med Pharmacol Sci; 2011 Sep; 15(9):1068-73. PubMed ID: 22013730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local inflammation occurs before systemic inflammation in patients with COPD.
    He Z; Chen Y; Chen P; Wu G; Cai S
    Respirology; 2010 Apr; 15(3):478-84. PubMed ID: 20210891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 70.